US Patent 11135255 Selection of bacterial strains useful in allergy treatment
Patent 11135255 was granted and assigned to BioGaia on October, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
Bacterial strains useful in prophylaxis, inhibition and/or treatment of an allergy in a mammal are selected by screening bacterial strains for capability of producing diacylglycerol kinase (DagK). A bacterial strain which is capable of producing DagK is then selected for use in prophylaxis, inhibition and/or treatment of the allergy.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Bhanu Priya Ganesh0
Bo Mollstam0
James Versalovic0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111352550
Date of Patent
October 5, 2021
0Patent Application Number
201705080
Date Filed
May 8, 2017
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11135255 Selection of bacterial strains useful in allergy treatment
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11135255
Date of patent
October 5, 2021
Patent application number
20170508
Date Filed
May 8, 2017
Find more entities like US Patent 11135255 Selection of bacterial strains useful in allergy treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.